Wednesday, 18 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Latest filing alerts

Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.

4:34 PM ET 10-Q
Financial Results Horizon Technology Finance Corp HRZN

Horizon Technology Finance Q3 2026 Results: Net Loss of $28.2M

Horizon Technology Finance Corp reported a net decrease in net assets resulting from operations of $28.2 million for the quarter ended September 30, 2026, driven by significant net unrealized depreciation on investments. Total investment income decreased to $24.1 million compared to $26.3 million in the prior year period, while net asset value per share declined to $5.56 from $6.98 at year-end 2025.

Key figure
Net loss $28.2M
4:34 PM ET 8-K
Leadership Change Micron Technology Inc MU

Micron Technology Leadership Change

Linnie M. Haynesworth notified Micron Technology of her intention to retire from the Board of Directors and will not stand for re-election at the fiscal 2026 annual shareholders meeting. She has served on the board since 2021, including roles as chair of the Security Committee and member of the Audit and Compensation Committees. Following her departure in January 2027, the board will be reduced to eight directors.

4:34 PM ET 8-K
Financial Results Egain Corp EGAN

Egain Financial Results

eGain Corp reported Q1 fiscal 2027 results with revenue of $21.9 million and non-GAAP EPS of $0.09, both exceeding the high end of company guidance. The company highlighted 11% year-over-year growth in AI customer annual recurring revenue (ARR) and repurchased $3.6 million of its common stock during the quarter.

Term
Q1 2027

“Being named a Leader in Gartner’s inaugural Magic Quadrant™ for Customer Service Knowledge Management Systems, with the highest product score for the Compliance-Driven Service Center use case in the companion Critical Capabilities report, is raising our visibility with enterprise buyers. As AI moves into production, enterprises need trusted, governed knowledge to deliver accurate answers and measurable results, a point our customers made clearly at Solve26. We’re focused on converting this interest into new customers and expansions.”

Ashu Roy, eGain’s CEO
4:34 PM ET 8-K
Financial Results Monster Beverage Corp MNST

Monster Beverage Financial Results

Monster Beverage Corporation reported third quarter 2026 net sales of $2.56 billion, a 16.7% increase year-over-year, driven by strong performance in the Monster Energy Drinks segment. Net income per diluted share rose 7.8% to $0.29, while international sales grew 28.1% to represent 47% of total revenue.

Term
Q3 2026
4:34 PM ET 8-K
Financial Results Mercer International Inc. MERC

Mercer International Financial Results

Mercer International reported third quarter 2026 results, showing an improved Operating EBITDA of negative $2.9 million compared to negative $28.1 million in the prior year period. The company highlighted a major balance sheet restructuring agreement to address $1.275 billion in senior notes and raise $400 million in new capital. The 'One Goal One Hundred' cost-savings program remains on track, achieving $22 million in savings during the quarter.

Term
Q3 2026

“As announced on November 2, 2026, we entered into restructuring support agreements with holders of more than 87% of the aggregate outstanding principal amount of our senior notes and with holders of a majority of the outstanding shares of our common stock that provide for a comprehensive recapitalization of the company (the "Recapitalization"). The transaction provides for, among other things, the exchange of approximately $1.1 billion of existing senior notes for equity, eliminates approximately $96 million of annual cash interest on our senior notes and provides for $400 million of new capital through a fully-backstopped rights offering of senior secured notes.”

Juan Carlos Bueno, Chief Executive Officer
4:34 PM ET 10-Q
Financial Results Valhi Inc VHI

Valhi Q3 2026 Results: Turns Profitable, Net Income $30.2M

Valhi, Inc. reported a significant turnaround for the nine months ended September 30, 2026, with net income of $84.1 million compared to $8.4 million in the prior year, driven by a 10.9% increase in net sales. The company's total assets stood at $2.58 billion, and it maintained a steady quarterly dividend of $0.08 per share.

Key figure
Net income $30.2M
4:34 PM ET 8-K
M&A Deal Pacira BioSciences, Inc. PCRX

Pacira BioSciences M&A Deal with Viatris Inc.

Pacira BioSciences provided a status update on its pending acquisition by Viatris Inc., noting that the tender offer for $36.50 per share commenced on October 30, 2026. Due to the pending merger, the company will not release Q3 2026 earnings or hold a conference call, and it has withdrawn its previously issued 2026 financial guidance.

Counterparty
Viatris Inc.
4:34 PM ET 8-K
Financial Results Tectonic Therapeutic, Inc. TECX

Tectonic Therapeutic Financial Results

Tectonic Therapeutic reported Q3 2026 financial results, ending the period with $234.7 million in cash which is expected to fund operations into Q1 2029. The company highlighted clinical progress, including favorable Phase 1a results for TX2100 and the dosing of the first patient in the Phase 2a ALPINE trial for TX45. Topline results for the APEX Phase 2 trial in PH-HFpEF are anticipated by the end of January 2027.

Term
Q3 2026

“The favorable safety, tolerability and PK results from the single ascending-dose portion of our TX2100 Phase 1a trial in healthy adult volunteers, together with FDA Fast Track designation for HHT and IND clearance for our Phase 1b trial, support our plans to evaluate TX2100 in patients with HHT.”

Alise Reicin, M.D., President and Chief Executive Officer

“We plan to initiate an open-label Phase 1b trial in patients with hematologic-support-dependent HHT by year-end 2026 and, in parallel, a placebo-controlled Phase 2 trial in patients with moderate-to-severe HHT in early 2027. We are also approaching a critical milestone for TX45, with topline results from our APEX Phase 2 trial in PH-HFpEF anticipated by the end of January 2027.”

Alise Reicin, M.D., President and Chief Executive Officer
4:34 PM ET 8-K
Investor Presentation Red Violet, Inc. RDVT

Red Violet Investor Presentation

Red Violet, Inc. has posted a new corporate investor presentation to its website and filed it with the SEC. The presentation provides a current overview of the company's AI-embedded identity intelligence platform, CORE, and includes financial results through September 30, 2026.

4:33 PM ET 8-K
Investor Presentation Verastem, Inc. VSTM

Verastem Investor Presentation

Verastem Oncology (VSTM) has published an updated corporate presentation for November 2026 detailing its pipeline of RAS/MAPK pathway-driven cancer therapies. The presentation highlights the commercialization strategy for AVMAPKI FAKZYNJA CO-PACK in recurrent low-grade serous ovarian cancer (LGSOC) and provides updates on its clinical trial programs, including RAMP 301 and collaborations with GenFleet Therapeutics.

4:33 PM ET 8-K
Financial Results Cryoport, Inc. CYRX

Cryoport Financial Results

Cryoport reported Q3 2026 revenue of $50.2 million, a 14% increase year-over-year, driven by 20% growth in commercial Cell and Gene Therapy revenue. The company achieved positive adjusted EBITDA of $1.1 million and raised its full-year 2026 revenue guidance to a range of $197 million to $199 million.

Term
Q3 2026

“Cryoport delivered third quarter revenue of $50.2 million, reflecting continued momentum across our core cell and gene therapy (CGT) business. Revenue from commercial CGT clients increased 20% year over year, BioStorage/BioServices revenue expanded 25%, and total Life Sciences Services revenue grew 18%, underscoring the strength of our integrated platform and the growing demand for our solutions.”

Jerrell Shelton, CEO of Cryoport

“Our strong year-to-date performance, combined with expanding support of commercial therapies, deepening customer relationships, a robust clinical trial pipeline, and continued demand for MVE’s industry-leading products, gives us confidence in our outlook. As a result, we are increasing our full-year 2026 revenue guidance to a range of $197 million to $199 million.”

Jerrell Shelton, CEO of Cryoport
4:33 PM ET 8-K
Financial Results Bimini Capital Management, Inc. BMNM

Bimini Capital Management Financial Results

Bimini Capital Management reported Q3 2026 net income of $1.0 million, or $0.10 per share, down from $1.8 million in the prior year period. Book value per share increased to $1.47 as of September 30, 2026, while the company highlighted the benefits of its strategic pivot toward a more diversified asset management model despite severe fixed-income market duress.

Term
Q3 2026

“The Company’s results for the quarter demonstrate the benefits of our recent pivot to a more diversified asset manager with less reliance on the levered RMBS strategy. The fixed income markets broadly, and the Agency RMBS market more specifically, generated poor results for the quarter, and the equity and investment grade credit markets were negatively impacted by the poor performance of AI/hyperscalers. Despite these pressures, Bimini was able to generate positive results for the quarter and believes it remains well positioned to continue to do so even while market conditions remain challenging.”

Robert E. Cauley, Chairman and Chief Executive Officer
4:33 PM ET 8-K
M&A Deal Transportation & Logistics Systems, Inc. TLSS

Transportation & Logistics Systems Signs $4.75M M&A Deal with Patriot Glass Solutions, LLC

Transportation and Logistics Systems, Inc. (TLSS) completed the acquisition of an 80% membership interest in Patriot Glass Solutions, LLC (PGS) and four related nanotechnology patents from Badcer Ops, Inc. The merger consideration consisted of 47,500 shares of Series J Senior Convertible Preferred Stock with an aggregate stated value of $4.75 million. Additionally, the company issued $351,800 in preferred stock to satisfy outstanding PGS promissory notes and expense advances.

Value
$4.75M
Counterparty
Patriot Glass Solutions, LLC
4:33 PM ET 10-Q
Financial Results Brilliant Earth Group, Inc. BRLT

Brilliant Earth Group Q3 2026 Results: Turns Profitable, Net Income $176K

For the three months ended September 30, 2026, Brilliant Earth Group, Inc. reported net sales of $112.8 million and returned to profitability with a net income of $2.4 million compared to a net loss in the prior year period. However, for the nine-month period, the company recorded a net loss of $5.2 million, reflecting ongoing challenges despite a 4.6% year-over-year increase in nine-month net sales.

Key figure
Net income $176K
4:33 PM ET 10-Q
Financial Results Warby Parker Inc. WRBY

Warby Parker Q3 2026 Results: Net Income $5.6M, Down 4.6% YoY

Warby Parker Inc. reported its third-quarter results for 2026, showing continued revenue growth driven by retail store expansions and increased active customer counts. The company highlighted improvements in gross margin and adjusted EBITDA, while maintaining its full-year outlook for sustainable growth and profitability.

Key figure
Net income $5.6M · -4.6% YoY
4:33 PM ET 8-K
Financial Results Gyre Therapeutics, Inc. GYRE

Gyre Therapeutics Financial Results

Gyre Therapeutics reported Q3 2026 revenue of $32.9 million and affirmed its full-year 2026 revenue guidance of $100.5 million to $111.0 million. The company is preparing for a potential China NMPA decision on its liver fibrosis candidate F351 by early 2027 and is advancing several protein degrader programs into clinical trials.

Term
Q3 2026

“I am pleased with our execution in the third quarter, our first full quarter incorporating Cullgen's operations within Gyre Therapeutics. We are advancing our protein degrader pipeline toward first-in-human data and initiating new clinical programs next year. Meanwhile, after recently completing an onsite inspection by China’s National Medical Products Administration, or NMPA, we continue to prepare for the China NMPA decision on F351 for CHB-induced liver fibrosis, which we anticipate launching, if approved, sometime in the first half of 2027. Together, these programs are expected to drive our next phase of growth and demonstrate the strength of our unique business model, combining U.S. innovation with capital-efficient operations in China.”

Dr. Ying Luo, President and Chief Executive Officer
4:33 PM ET 8-K
Financial Results Red Violet, Inc. RDVT

Red Violet Financial Results

Red Violet reported record third-quarter 2026 revenue of $27.8 million, a 20% increase year-over-year, driven by demand for identity resolution and fraud prevention solutions. The company achieved record operating cash flow of $12.7 million and surpassed $100 million in trailing twelve-month revenue for the first time.

Term
Q3 2026

“red violet delivered another record revenue quarter, surpassing $100 million in trailing twelve-month revenue for the first time, and generating record operating cash flow. The continued expansion of digital interactions, coupled with increasingly sophisticated AI-driven fraud, is fueling demand for identity resolution, fraud prevention, and compliance solutions.”

Derek Dubner, red violet’s CEO

“Our proprietary platform and longitudinal identity graph deliver accurate identity intelligence that informs critical decisions and supports customers’ daily workflows. We believe these secular tailwinds, combined with our strengthening competitive advantages, position us to capture a growing share of this expanding market.”

Derek Dubner, red violet’s CEO
4:33 PM ET 8-K
Business Update Nuscale Power Corp SMR

Nuscale Power Business Update

NuScale Power reported its third quarter 2026 operational results, highlighting a transition from development to physical production through a fabrication agreement with Doosan Enerbility. The company maintained a strong liquidity position with $1.9 billion in cash and investments while advancing its supply chain through AI tool deployment and reactor safety component fabrication.

4:33 PM ET 10-Q
Financial Results Vaxart, Inc. VXRT

Vaxart Q3 2026 Results: Net Loss of $17.7M, Loss Widens

This document outlines Vaxart, Inc.'s Director Resignation Policy, requiring directors in uncontested elections to tender their resignation if they receive a 'Majority Withheld Vote.' The Nominating and Governance Committee and the Board must evaluate such resignations based on factors like director qualifications and regulatory compliance within 90 days.

Key figure
Net loss $17.7M
4:33 PM ET Form 4
Insider Selling California Water Service Group CWT

California Water Service Group Director Carol M. Pottenger Sells $133K of Stock

Carol M. Pottenger, Director, sold 2,657 shares of California Water Service Group at $49.92 a share, worth $133K in total on Nov 4, 2026. Shares held after the trade: 16,530 (-13.8%).

Value
$133K
Shares
2,657
Price
$49.92
Role
Director
Holding change
-13.8%
Trade date
Nov 4, 2026
4:33 PM ET 10-Q
Financial Results Pdf Solutions Inc PDFS ▶ Call

Pdf Solutions Q3 2026 Results: Net Income $6.84M, Up 428.7% YoY

PDF Solutions reported total revenues of $68.3 million for the third quarter of 2026, a 20% increase compared to the same period in 2025, driven primarily by growth in Platform revenue. Net income improved significantly to $6.8 million for the quarter, while the company strengthened its cash position to $107.1 million following a secondary stock offering that raised approximately $81.8 million.

Key figure
Net income $6.84M · +428.7% YoY
4:33 PM ET 10-Q
Financial Results Dorchester Minerals, L.P. DMLP

Dorchester Minerals Q3 2026 Results: Net Income $27.6M, Up 146.9% YoY

Dorchester Minerals, L.P. reported a significant increase in net income to $87.6 million for the nine months ended September 30, 2026, compared to $41.2 million for the same period in 2025. This growth was driven by higher royalty and net profits interest revenues, while the partnership continued its strategy of acquiring oil and natural gas properties through the issuance of common units.

Key figure
Net income $27.6M · +146.9% YoY
4:33 PM ET 8-K
Loan & Debt Xometry, Inc. XMTR

Xometry $85M Debt Financing with U.S. Bank Trust Company, National Association

Xometry, Inc. issued a notice of redemption for all $85.0 million aggregate principal amount of its 1.00% Convertible Senior Notes due 2027. The notes will be redeemed on November 20, 2026, at 100% of the principal amount plus accrued interest, unless holders elect to convert their notes into Class A common stock before the November 19 deadline.

Value
$85M
Counterparty
U.S. Bank Trust Company, National Association
4:33 PM ET 10-Q
Financial Results Eagle Bancorp Inc EGBN

Eagle Bancorp Q3 2026 Results: Turns Profitable, Net Income $24.2M

Eagle Bancorp reported a net income of $24.2 million for the third quarter of 2026, a significant recovery from a $67.5 million net loss in the same period of 2025, which was primarily driven by a large provision for credit losses. Total assets decreased to $9.5 billion from $10.5 billion at year-end 2025, reflecting a reduction in loans held for investment and total deposits.

Key figure
Net income $24.2M
4:33 PM ET 8-K
Dividend Horizon Technology Finance Corp HRZN

Horizon Technology Finance Dividend

Horizon Technology Finance Corporation's Board of Directors declared monthly cash distributions for January, February, and March 2027, totaling $0.18 per share. The distributions of $0.06 per share each month are payable to stockholders of record as of December 16, 2026, January 19, 2027, and February 18, 2027.

Term
Q1 2027
4:33 PM ET 8-K
Executive Compensation Goodyear Tire & Rubber Co GT

Goodyear Tire & Rubber Executive Compensation

The Goodyear Tire & Rubber Company elected David E. Phillips as Executive Vice President, Chief Legal Officer and Head of Enterprise Transformation, effective November 1, 2026. In connection with his expanded role, Mr. Phillips will receive an annual base salary of $850,000, an annual incentive target of $850,000, and a planned restricted stock unit grant valued at $1.25 million in February 2027.

4:33 PM ET 8-K
Capital Raise BlackRock Monticello Debt Real Estate Investment Trust

BlackRock Monticello Debt Real Estate Investment Trust Capital Raise of $19.8M

BlackRock Monticello Debt Real Estate Investment Trust sold 783,564.3076 common shares in a continuous private offering for aggregate consideration of approximately $19.77 million. The sale included Class I, Class S, and Class E common shares and was conducted as an unregistered sale exempt under Regulation D.

Value
$19.8M
4:33 PM ET 8-K
Financial Results Morgan Stanley Direct Lending Fund MSDL

Morgan Stanley Direct Lending Fund Financial Results

Morgan Stanley Direct Lending Fund reported Q3 2026 net investment income of $40.3 million, or $0.48 per share, and a net asset value of $18.76 per share. The company also declared a regular Q4 dividend of $0.45 per share and a supplemental dividend of $0.015 per share, while announcing a reduction in management and incentive fees effective January 2027.

Term
Q3 2026
4:33 PM ET 8-K
Shareholder Meeting Lantronix Inc LTRX

Lantronix Shareholder Meeting

Lantronix held its 2026 Annual Meeting of Stockholders where shareholders elected five directors and ratified Baker Tilly US, LLP as the independent auditor for fiscal year 2027. Stockholders also approved an amendment to the 2020 Performance Incentive Plan to increase the share pool by 1,800,000 shares and passed a non-binding advisory vote on executive compensation.

4:33 PM ET 8-K
Shareholder Meeting Lifeward Ltd. LFWD

Lifeward Shareholder Meeting

Lifeward Ltd. held its 2026 Annual and Extraordinary General Meeting of Shareholders on October 30, 2026. Shareholders approved the re-election of Haggai Zamir and Avi Gabay as Class III directors, the election of Ariel Kallner as an external director, and compensation packages for directors and Interim CEO Josh Hexter; however, Proposal 6 did not receive the requisite votes for approval.

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.